Case Note & Summary
The Supreme Court of India initiated a suo motu writ petition on 22 April 2021 to address the management of the COVID-19 pandemic during its second wave, focusing on the distribution of essential supplies and services. The Court held hearings involving submissions from the Union of India, State/Union Territory Governments, appointed amici curiae, and intervenors. On 30 April 2021, it passed a detailed order covering vaccination policy, medical oxygen supply, drug availability, healthcare infrastructure, workforce issues, and freedom of speech, directing the Union of India to reconsider its policies based on the Court's observations. Subsequently, a National Task Force was constituted on 6 May 2021 to provide a scientific public health response. In hearings on 31 May 2021, the Court narrowed its focus to the vaccination policy, as the pandemic situation had improved but vaccination remained crucial for long-term control. The core legal issues revolved around the constitutionality and equity of the Liberalized Vaccination Policy implemented from 1 May 2021, which shifted procurement responsibilities to State/Union Territory Governments and private hospitals for the 18-44 age group, leading to differential pricing and potential inequalities. The Union of India, represented by the Solicitor General, argued that the vaccination drive would be completed by December 2021, with efforts to secure vaccine supplies, and denied that the policy caused competition among States. The amici curiae raised concerns about the policy deviating from the historical Universal Immunization Programme, creating a monopoly for manufacturers, imposing burdens on poorer individuals and financially strained States, and disrupting the constitutional balance of powers between the Centre and States. The Court analyzed these arguments in light of constitutional provisions, including Entries in the Seventh Schedule related to public health and inter-State matters, and fundamental rights to health and equality under Articles 14 and 21. It emphasized a bounded-deliberative approach, respecting separation of powers while ensuring judicial review to protect citizens' rights. The Court concluded by directing the Union of India to review and reconsider the Liberalized Vaccination Policy, taking into account the observations on procurement, pricing, and distribution to ensure equitable access for all citizens, and to continue monitoring pandemic-related issues alongside the National Task Force.
Headnote
A) Constitutional Law - Federalism and Public Health - Entries in Seventh Schedule - Constitution of India, 1950, Seventh Schedule, List I Entry 81, List II Entry 6, List III Entry 29 - The Court examined the constitutional distribution of powers between the Centre and States regarding public health and pandemic management. It noted that while public health is a State subject under Entry 6 of List II, inter-State migration and quarantine under Entry 81 of List I and prevention of infectious diseases under Entry 29 of List III involve Central responsibilities. The Liberalized Vaccination Policy was scrutinized for potentially conflicting with this balance by shifting burden to States. Held that the Central Government must work in tandem with State Governments in vaccination policy. (Paras 8, 9) B) Constitutional Law - Right to Health and Equality - Equitable Access to Vaccines - Constitution of India, 1950, Articles 14, 21 - The Court addressed concerns that the Liberalized Vaccination Policy creates unequal treatment based on age and socio-economic status, with differential pricing for vaccines procured by the Centre versus States/UTs. It highlighted that poor individuals in the 18-44 age group might bear costs, and financially distressed States may struggle to afford vaccines, impacting equitable access. The Court directed the Union of India to reconsider its policy to ensure no citizen is deprived of vaccination due to inability to pay. (Paras 8, 9) C) Administrative Law - Judicial Review of Executive Policy - Bounded-Deliberative Approach - Not mentioned - The Court adopted a bounded-deliberative approach in reviewing the Union of India's vaccination policy, emphasizing that its role is to ensure policies are constitutionally compliant and protect fundamental rights, not to dictate policy. It directed the Central Government to re-examine the Liberalized Vaccination Policy, taking into account the Court's observations on procurement, pricing, and distribution, while allowing for executive discretion within constitutional bounds. (Paras 2, 5) D) Public Health Law - Vaccination Policy and Procurement - Single Procurement Model vs. Liberalized Policy - Not mentioned - The Court compared the Universal Immunization Programme (single procurement by Centre) with the Liberalized Vaccination Policy (procurement by States/UTs and private hospitals). It noted issues such as differential pricing, competition among States, and monopoly advantages for manufacturers. The Court urged the Union of India to ensure adequate vaccine supply and consider reverting to a centralized procurement model to lower costs and improve efficiency. (Paras 8, 9)
Issue of Consideration
Whether the Liberalized Vaccination Policy adopted by the Union of India for COVID-19 vaccination, involving differential pricing and procurement by State/Union Territory Governments and private hospitals, is constitutionally sound and ensures equitable access to vaccines for all citizens.
Final Decision
The Supreme Court directed the Union of India to review and reconsider the Liberalized Vaccination Policy, taking into account the Court's observations on procurement, pricing, and distribution to ensure equitable access for all citizens, and to continue monitoring pandemic-related issues alongside the National Task Force.
Law Points
- Constitutional law
- separation of powers
- right to health
- public health policy
- federalism
- judicial review of executive policy
- equitable distribution of essential supplies
